Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 30.49-6.23-32.1036.7145.25

What is the latest Core EBITDA Growth ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Growth ratio of DIVIS LABORATORIES is 30.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202530.49
Mar2024-6.23
Mar2023-32.10
Mar202236.71
Mar202145.25

How is Core EBITDA Growth of DIVIS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 30.49
Positive
Mar2024 -6.23
Negative
Mar2023 -32.1
Negative
Mar2022 36.71
-18.87
Mar2021 45.25 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹172,308.2 Cr 1.8% 0.9% 6.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,160.0 Cr 1.7% 7.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,440.0 Cr 1.3% 4.4% 14.9% Stock Analytics
CIPLA ₹123,149.0 Cr 0.9% -2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,369.0 Cr 0.5% -3.1% 3.3% Stock Analytics
MANKIND PHARMA ₹92,837.8 Cr 0.3% -6.5% -13.5% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

1.8%

0.9%

6.1%

SENSEX

0.1%

1.1%

8.4%


You may also like the below Video Courses